525 related articles for article (PubMed ID: 7988649)
1. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
Rosenzweig-Lipson S; Bergman J
Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
Rosenzweig-Lipson S; Bergman J
J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
[TBL] [Abstract][Full Text] [Related]
3. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
4. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
Tidey JW; Bergman J
J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
[TBL] [Abstract][Full Text] [Related]
5. Behavioral effects of D1 and D2 dopamine receptor antagonists in squirrel monkeys.
Bergman J; Madras BK; Spealman RD
J Pharmacol Exp Ther; 1991 Sep; 258(3):910-7. PubMed ID: 1890625
[TBL] [Abstract][Full Text] [Related]
6. Effects of dopamine D1 ligands on eye blinking in monkeys: efficacy, antagonism, and D1/D2 interactions.
Jutkiewicz EM; Bergman J
J Pharmacol Exp Ther; 2004 Dec; 311(3):1008-15. PubMed ID: 15292458
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of cocaine-antagonist properties and motoric effects of the D1 receptor partial agonists SKF 83959 and SKF 77434.
Platt DM; Rowlett JK; Spealman RD
J Pharmacol Exp Ther; 2000 Jun; 293(3):1017-26. PubMed ID: 10869406
[TBL] [Abstract][Full Text] [Related]
8. Selective dopamine antagonist pretreatment on the antiparkinsonian effects of benzazepine D1 dopamine agonists in rodent and primate models of Parkinson's disease--the differential effects of D1 dopamine antagonists in the primate.
Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
Psychopharmacology (Berl); 1995 Feb; 117(4):403-12. PubMed ID: 7604140
[TBL] [Abstract][Full Text] [Related]
9. Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.
Deveney AM; Waddington JL
Eur J Pharmacol; 1996 Dec; 317(2-3):175-81. PubMed ID: 8997598
[TBL] [Abstract][Full Text] [Related]
10. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the sensitivity of operant timing behaviour to stimulation of D1 dopamine receptors.
Cheung TH; Bezzina G; Hampson CL; Body S; Fone KC; Bradshaw CM; Szabadi E
Psychopharmacology (Berl); 2007 Dec; 195(2):213-22. PubMed ID: 17668188
[TBL] [Abstract][Full Text] [Related]
12. Conditioning to injection procedures and repeated testing increase SCH 23390-induced catalepsy in mice.
Chinen CC; Frussa-Filho R
Neuropsychopharmacology; 1999 Nov; 21(5):670-8. PubMed ID: 10516963
[TBL] [Abstract][Full Text] [Related]
13. Existence of dopamine D1 receptor on the sympathetic nerve endings in the guinea-pig vas deferens.
Furukawa T; Morishita H
Eur J Pharmacol; 1997 Jun; 328(2-3):229-34. PubMed ID: 9218705
[TBL] [Abstract][Full Text] [Related]
14. Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434.
Abrahams BS; Rutherford JD; Mallet PE; Beninger RJ
Eur J Pharmacol; 1998 Feb; 343(2-3):111-8. PubMed ID: 9570457
[TBL] [Abstract][Full Text] [Related]
15. The dopamine D(1) receptor agonist SKF-82958 serves as a discriminative stimulus in the rat.
Haile CN; Carey G; Varty GB; Coffin VL
Eur J Pharmacol; 2000 Jan; 388(2):125-31. PubMed ID: 10666503
[TBL] [Abstract][Full Text] [Related]
16. Interactions between cocaine and dopamine agonists on cardiovascular function in squirrel monkeys.
Schindler CW; Gilman JP; Bergman J; Mello NK; Woosley RL; Goldberg SR
J Pharmacol Exp Ther; 2002 Jan; 300(1):180-7. PubMed ID: 11752114
[TBL] [Abstract][Full Text] [Related]
17. Behavioral effects of the R-(+)- and S-(-)-enantiomers of the dopamine D(1)-like partial receptor agonist SKF 83959 in monkeys.
Desai RI; Neumeyer JL; Paronis CA; Nguyen P; Bergman J
Eur J Pharmacol; 2007 Mar; 558(1-3):98-106. PubMed ID: 17207791
[TBL] [Abstract][Full Text] [Related]
18. Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.
Witkin JM; Newman AH; Nowak G; Katz JL
J Pharmacol Exp Ther; 1993 Oct; 267(1):266-74. PubMed ID: 7901394
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
Ralph RJ; Caine SB
J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
[TBL] [Abstract][Full Text] [Related]
20. Stimulating dopamine D1 receptors increases the locomotor activity of developing rats.
Shieh GJ; Walters DE
Eur J Pharmacol; 1996 Sep; 311(2-3):103-7. PubMed ID: 8891588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]